Neonatal abstinence syndrome in European and North American neonates: Diff erences in clinical characteristics derived from a prospective randomized trial

Klinische Padiatrie

Volumn 226, Issue 5, 2014, Pages 274-280

  Kirchner, L ^a   Graf Rohrmeister, K ^a   Klebermass Schrehof, K ^a   Weninger, M ^a   Jagsch, R ^b   Metz, V ^c   Unger, A ^c   Fischer, G ^c  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

buprenorphine; intrauterine opioid exposure; methadone; morphine; neonatal abstinence syndrome

Indexed keywords

BUPRENORPHINE; COCAINE; METHADONE; MORPHINE;

ANCESTRY GROUP; APGAR SCORE; ARTICLE; BEHAVIOR DISORDER; BIRTH WEIGHT; BODY HEIGHT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EUROPEAN AMERICAN; FEMALE; GASTROINTESTINAL SYMPTOM; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MOTHER NEONATAL ABSTINENCE SCORING TOOL; NEUROLOGIC DISEASE; NEWBORN; NEWBORN ASSESSMENT; NORTH AMERICAN; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; ROOMING IN; RURAL POPULATION; SCORING SYSTEM; TREATMENT DURATION; URBAN POPULATION; URBAN RURAL DIFFERENCE; WITHDRAWAL SYNDROME; CLINICAL TRIAL; COMPARATIVE STUDY; CULTURAL FACTOR; EUROPE; MALE; MULTICENTER STUDY; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; RISK FACTOR; UNITED STATES;

CROSS-CULTURAL COMPARISON; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; UNITED STATES; URBAN POPULATION;

EID: 84906935369     PISSN: 03008630     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0034-1372586     Document Type: Article

References (30)

1. Abdel-Latif M. E., Pinner J., Clews S. et al. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics: 2006; 117 e1163 e1169 (Pubitemid 46071213)
2. Baewert A., Jagsch R., Winklbaur B. et al. Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics. Eur Addict Res: 2012; 18 130 139
3. Belcheva M. M., Bohn L. M., Ho M. T. et al. Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine. Brain Res Dev Brain Res: 1998; 111 35 42 (Pubitemid 28520243)
4. Buchi K. F., Suarez C., Varner M. W. The prevalence of prenatal opioid and other drug use in Utah. Am J Perinatol: 2013; 30 241 244
5. Dabek M. T., Poeschl J., Englert S. et al. Treatment of neonatal abstinence syndrome in preterm and term infants. Klin Paediatr: 2013; 255 252 256
6. Finnegan L. P., Connaughton J. F., Kron R. E. et al. Neonatal abstinence syndrome: assessment and management. Addict Dis: 1975; 2 141 158
7. Finnegan L. P., Kron R. E., Connaughton J. F. et al. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int J Clin Pharmacol Biopharm: 1975; 12 19 32
8. nd ed. St. Louis Mosby: 1992; 1367 1378
9. Fischer G., Ortner R., Rohrmeister K. et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction: 2006; 101 275 281 (Pubitemid 43351601)
10. Gortner L. Neonatal abstinence syndrome - change in therapy options. Klin Padiatr: 2013; 225 243 244
11. Hünseler C., Brückle M., Roth B. et al. Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr: 2013; 225 247 251
12. Jansson L. M., Velez M., Harrow C. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag: 2009; 5 47 55
13. Jones H. E., Johnson R. E., Jasinski D. R. et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend: 2005; 79 1 10 (Pubitemid 41557119)
14. Jones H. E., O'Grady K. E., Malfi D. et al. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict: 2008; 17 372 386
15. Jones H. E., Martin P. R., Heil S. H. et al. Treatment of opioid dependent pregnant women: clinical and research issues. J Subst Abuse Treat: 2008; 35 245 259
16. Jones H. E., Kaltenbach K., Heil S. H. et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med: 2010; 363 2320 2331
17. Kakko J., Heilig M., Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend: 2008; 96 69 78
18. Kaltenbach K., Berghella V., Finnegan L. Opioid dependency during pregnancy. Effects and management. Obstet Gynecol Clin North Am: 1998; 25 139 151 (Pubitemid 28141705)
19. Lacroix I., Berrebi A., Garipuy D. et al. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Eur J Clin Pharmacol: 2011; 67 1053 1059
20. Mattick R. P., Kimber J., Breen C. et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev: 2008; 16 CD002207
21. Mattick R. P., Breen C., Kimber J. et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev: 2009; 8 CD002209
22. Müller M. J., Lange M., Paul T. et al. Breast feeding during methadon- and buprenorphin therapy. Klin Padiatr: 2011; 223 408 413
23. Nanovskaya T., Deshmukh S., Brooks M. et al. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther: 2002; 300 26 33 (Pubitemid 34028504)
24. Osborn D. A., Jeffery H. E., Cole M. J. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Rev: 2010; 6 CD002059
25. Pizarro D., Habli M., Grier M. et al. Higher maternal doses of methadone does not increase neonatal abstinence syndrome. J Subst Abuse Treat: 2011; 40 295 298
26. Poeschl J., Dabek M., Englert S. et al. Treatment of neonatal abstinence syndrome in preterm and term neonates. Klin Padiatr: 2013; 225 252 256
27. Schindler S. D., Eder H., Ortner R. et al. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction: 2003; 98 103 110 (Pubitemid 36044342)
28. Schneck H. Narcotic withdrawal symptoms in the newborn infant resulting from maternal addiction. J Pediatr: 1958; 52 584 587
29. Unger A. S., Martin P. R., Kaltenbach K. et al. Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment. Eur Addict Res: 2010; 16 99 107
30. Winklbaur B., Kopf N., Ebner N. et al. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction: 2008; 103 1429 1440